Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
By Dennis Thompson HealthDay ReporterWEDNESDAY, May 6, 2026 (HealthDay News) — The number of weight-loss surgery procedures in the United States is dropping rapidly in the face of cutting-edge drugs like Ozempic and Zepbound, a new study says. These procedures dropped by more than 20% between 2022 and 2024, falling below 200,000 for the first …